目的 探究宏基因组二代测序（metagenomic next-generation sequencing，mNGS）技术检测伴有中枢神经系统受累的噬血细胞综合征患儿颅内EB病毒（Epstein-Barr virus，EBV）感染的应用价值及临床意义。 方法 回顾性分析30例伴有中枢神经系统受累的噬血细胞综合征患儿的脑脊液mNGS结果，与脑脊液EBV-DNA定性检测、血清EBV抗体谱检测结果进行比较，以治疗前后血清EBV-DNA拷贝数变化反映针对性治疗效果。 结果 脑脊液mNGS EBV检测阳性率为100%（30/30），高于脑脊液EBV-DNA定性检测阳性率（10%，3/30；P<0.001），与血清EBV抗体谱检测阳性率（93%，28/30）比较差异无统计学意义（P>0.05）。中位mNGS EBV检出序列数为2 400，治疗前血清EBV-DNA拷贝数与EBV检出序列数呈中度正相关（rs=0.693，P<0.001）。多元线性回归分析结果显示，治疗前血清EBV-DNA拷贝数越高，脑脊液mNGS EBV检出序列数越高（P<0.05）。 结论 EBV相关噬血细胞综合征容易诱发EBV感染引起的病毒性脑炎，mNGS可以显著提高脑脊液EBV检测的阳性率，协助临床诊断。
Abstract
Objective To study the value of metagenomic next-generation sequencing (mNGS) in detecting intracranial Epstein-Barr virus (EBV) infection in children with hemophagocytic syndrome (HPS) with central nervous system involvement. Methods A retrospective analysis was performed for the cerebrospinal fluid mNGS results of 30 HPS children with central nervous system involvement, which were compared with the results of cerebrospinal fluid EBV-DNA detection and serum EBV antibody profile. The change in serum EBV-DNA copy number after treatment was used to evaluate the efficacy of targeted therapy. Results The positive rate of EBV in cerebrospinal fluid determined by mNGS was significantly higher than that of EBV-DNA in cerebrospinal fluid (100% vs 10%, P<0.001) and had no significant difference from the positive rate of serum EBV antibody profile (100% vs 93%, P>0.05). The median number of sequences determined by mNGS was 2 400, and serum EBV-DNA copy number before treatment was moderately positively correlated with the number of EBV sequences (rs=0.693, P<0.001). The multiple linear regression analysis showed that the number of sequences determined by mNGS in cerebrospinal fluid increased with the increase in serum EBV-DNA copy number before treatment (P<0.05). Conclusions EBV-associated HPS often results in EBV-infected viral encephalitis, and mNGS can significantly increase the detection rate of EBV in cerebrospinal fluid, which may help with clinical diagnosis.
关键词
噬血细胞综合征 /
EB病毒 /
宏基因组二代测序 /
儿童
Key words
Hemophagocytic syndrome /
Epstein-Barr virus /
Metagenomic next-generation sequencing /
Child
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
1 噬血细胞综合征中国专家联盟, 中华医学会儿科学分会血液学组. 噬血细胞综合征诊治中国专家共识[J]. 中华医学杂志, 2018, 98(2): 91-95. DOI: 10.3760/cma.j.issn.0376-2491.2018.02.004.
2 黄婕, 王楠, 吴鹏, 等. 儿童噬血细胞综合征伴中枢神经系统受累临床及生存分析[J]. 南京医科大学学报(自然科学版), 2020, 40(8): 1176-1180. DOI: 10.7655/NYDXBNS20200816.
3 Henter JI, Horne A, Aricó M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis[J]. Pediatr Blood Cancer, 2007, 48(2): 124-131. PMID: 16937360. DOI: 10.1002/pbc.21039.
4 Janka GE, Lehmberg K. Hemophagocytic syndromes—an update[J]. Blood Rev, 2014, 28(4): 135-142. PMID: 24792320. DOI: 10.1016/j.blre.2014.03.002.
5 Vine LJ, Shepherd K, Hunter JG, et al. Characteristics of Epstein-Barr virus hepatitis among patients with jaundice or acute hepatitis[J]. Aliment Pharmacol Ther, 2012, 36(1): 16-21. PMID: 22554291. DOI: 10.1111/j.1365-2036.2012.05122.x.
6 Fryer JF, Heath AB, Wilkinson DE, et al. A collaborative study to establish the 1st WHO international standard for Epstein-Barr virus for nucleic acid amplification techniques[J]. Biologicals, 2016, 44(5): 423-433. PMID: 27461128. DOI: 10.1016/j.biologicals.2016.04.010.
7 Dunmire SK, Verghese PS, Balfour HH. Primary Epstein-Barr virus infection[J]. J Clin Virol, 2018, 102: 84-92. PMID: 29525635. DOI: 10.1016/j.jcv.2018.03.001.
8 Han D, Li Z, Li R, et al. mNGS in clinical microbiology laboratories: on the road to maturity[J]. Crit Rev Microbiol, 2019, 45(5-6): 668-685. PMID: 31691607. DOI: 10.1080/1040841X.2019.1681933.
9 Zhang B, Zhou J, Gui R, et al. Metagenomic next generation sequencing in the detection of pathogens in cerebrospinal fluid of patients after alternative donor transplantation: a feasibility analysis[J]. Front Cell Infect Microbiol, 2021, 11: 720132. PMID: 34595132. PMCID: PMC8476959. DOI: 10.3389/fcimb.2021.720132.
10 Wang S, Chen Y, Wang D, et al. The feasibility of metagenomic next-generation sequencing to identify pathogens causing tuberculous meningitis in cerebrospinal fluid[J]. Front Microbiol, 2019, 10: 1993. PMID: 31551954. PMCID: PMC6733977. DOI: 10.3389/fmicb.2019.01993.
11 Piantadosi A, Mukerji SS, Ye S, et al. Enhanced virus detection and metagenomic sequencing in patients with meningitis and encephalitis[J]. mBio, 2021, 12(4): e0114321. PMID: 34465023. PMCID: PMC8406231. DOI: 10.1128/mBio.01143-21.
12 Carbo EC, Blankenspoor I, Goeman JJ, et al. Viral metagenomic sequencing in the diagnosis of meningoencephalitis: a review of technical advances and diagnostic yield[J]. Expert Rev Mol Diagn, 2021, 21(11): 1139-1146. PMID: 34607520. DOI: 10.1080/14737159.2021.1985467.
13 Ramachandran PS, Wilson MR. Metagenomics for neurological infections—expanding our imagination[J]. Nat Rev Neurol, 2020, 16(10): 547-556. PMID: 32661342. PMCID: PMC7356134. DOI: 10.1038/s41582-020-0374-y.
14 施鹏飞, 谢亚萍, 徐颖, 等. 成人EB病毒阳性T细胞淋巴组织增殖性疾病13例临床分析[J]. 中华血液学杂志, 2017, 38(3): 243-246. PMID: 28395451. PMCID: PMC7348377. DOI: 10.3760/cma.j.issn.0253-2727.2017.03.014.
15 Shahan B, Choi EY, Nieves G. Cerebrospinal fluid analysis[J]. Am Fam Physician, 2021, 103(7): 422-428. PMID: 33788511
16 Tyler KL. Acute viral encephalitis[J]. N Engl J Med, 2018, 379(6): 557-566. PMID: 30089069. DOI: 10.1056/NEJMra1708714.
17 Gulley ML, Tang W. Laboratory assays for Epstein-Barr virus-related disease[J]. J Mol Diagn, 2008, 10(4): 279-292. PMID: 18556771. PMCID: PMC2438195. DOI: 10.2353/jmoldx.2008.080023.
18 Zykova TA, Shevyakova EA, Pustovaya IV, et al. Differences in serological profiles of Epstein-Barr virus infection in patients with head and neck tumors and lymphomas[J]. J Clin Oncol, 2022, 40(16_suppl): e18055. DOI: 10.1200/JCO.2022.40.16_suppl.e18055.
19 Williams S, Hassan-Smith G. 075?Meningitis management audit at a single centre: further support for culture-independent techniques in diagnosing meningitis[J]. J Neurol Neurosurg Psychiatry, 2019, 90(12): A26. DOI: 10.1136/jnnp-2019-ABN-2.87.
20 Piantadosi A, Mukerji S, Ye S, et al. 868. Prospective pathogen detection in patients with central nervous system inflammation using metagenomic sequencing[J]. Open Forum Infect Dis, 2018, 5(suppl_1): S23. DOI: 10.1093/ofid/ofy209.053.
基金
国家重点研发计划项目（2021YFC2701705）。
PDF(538 KB)
